DEA's Marijuana Hypocrisy Laid Bare: As Rescheduling Looms, Agency's Ethical Failures and Research Obstruction Spark Outrage
MMJ BioPharma Cultivation 's case exposes DEA's Diversion Control Division as a cartel of obstructionists who have abandoned science, betrayed public trust, and refused to follow the law.
New DEA Administrator Terrance Cole inherited a mess. But now he has a chance to do something Judge Mulrooney, Thomas Prevoznik, Matthew Strait and Aarathi Haig never would: Tell the truth. Follow the law. And approve MMJ's long-blocked registration so clinical trials can finally begin.
WASHINGTON, DC / ACCESS Newswire / July 30, 2025 / While the Drug Enforcement Administration (DEA) teases potential marijuana rescheduling, its actions reveal a disturbing pattern of hypocrisy: blocking federally compliant medical research while turning a blind eye to illegal corporate exports and harboring attorneys who flout ethical standards.
For companies like MMJ BioPharma Cultivation-which has meticulously followed federal law for seven years-the DEA's conduct suggests not bureaucratic inertia, but deliberate sabotage of scientific progress, underscored by ethical breaches within its own ranks.
The Haig Scandal: A DEA Attorney Operating Without Legal Standing
At the center of the storm is DEA attorney Aarathi Haig, who continues to lead high-profile cases, including the agency's fight against MMJ BioPharma Cultivation, despite being ineligible for a Certificate of Good Standing with the New Jersey Bar. Records show Haig:
Federal law (28 U.S.C. § 530B) mandates that government attorneys comply with state bar rules, yet the DEA has taken no apparent action against Haig. 'This isn't about paperwork-it's about a pattern of disregard for the law,' said Duane Boise, CEO of MMJ BioPharma. 'The DEA demands compliance from others while ignoring its own obligations' .
MMJ BioPharma Cultivation's Ordeal: A Case Study in DEA Corrupt Obstruction
MMJ BioPharma's struggle exposes the DEA's double standard:
Meanwhile, the DEA ignores recreational cannabis companies illegally exporting THC products to Europe while stonewalling MMJ's compliant research.
The Bigger Picture: A System Rigged Against Science
The DEA's own Diversion Control Manual (Sections 5202.5, 5201.12) mandates support for 'bona fide Schedule I research' and expedited approvals-policies Prevoznik and Haig have blatantly ignored. The agency's actions reveal:
A Call for Accountability
With incoming DEA Administrator Terrance Cole poised to take office, advocates demand:
'The DEA administrative hearing system is a constitutional dead man walking,' Boise declared. 'Every day it clings to this broken system, it digs its grave deeper'
The public deserves answers. The patients deserve justice. The time for DEA accountability is now.
CONTACT:
Madison Hisey
[email protected]
203-231-8583
SOURCE: MMJ International Holdings
press release
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New York Post
10 hours ago
- New York Post
NY authorities crack $2.5M drug smuggling ring, seize over 2K pounds of illegal weed : DA's office
Six people were arrested after authorities busted an unlicensed cross-country pot smuggling operation this week in NYC that included the seizure of more than 2,000 pounds of marijuana worth over $2.5 million. The suspects were using tractor-trailor-style trucks to bring the pot and various cannabis products from California to a SecureSpace self-storage unit in Maspeth, officials said Friday. From there, the goods would be divided and transferred to another storage unit, given to a distributor or sold directly to customers, authorities said. Advertisement Authorities seized more than 2,000 pounds of illegal cannabis products worth over $2.5 million that were smuggled into Queens from California, officials announced Friday. BritCats Studio – The shady enterprise had allegedly been going on since April. The joint investigation was conducted by members of the Queens DA's office, the Drug Enforcement Administration's New Jersey Field Division and the city Sheriff NYPD Cannabis Task Force. Nearly 2,000 pounds of THC flower, along with hundreds of pre-packed, one-pound weed bags, pre-rolled cannabis cigarettes and nearly 1,000 pounds of THC vape pens, were allegedly discovered Thursday after investigators executed various search warrants in Maspeth and Long Island City, the DA's office said. Advertisement Manhattanites Eduardo Lopez, 29, and Courtney Ferguson, 40; Erzhena Mitupova, 34, and Anna Migal, 47, both of Kew Gardens; 24-year-old Jose Carbajal Enamorado of Jackson Heights and 24-year-old Emerson Ramos Garcia of Bayside were all arrested after authorities alleged none were licensed to sell cannabis in New York. 'These types of THC products that are sold illegally very often lead to harm in our communities,' Queens District Attorney Melinda Katz said in response to the bust. Stephen Yang All six men were charged with first degree criminal possession of cannabis and ordered to return to criminal court on various dates in September and October by a Queens judge during their arraignments Thursday. Advertisement If convicted, they each face a potential maximum sentence of 2 ⅓ years to seven years in prison. 'These types of THC products that are sold illegally very often lead to harm in our communities. It is the reason that legal shops go through a rigorous approval process by the state,' Katz said in response to the bust.
Yahoo
16 hours ago
- Yahoo
【話題】女子百米世界冠軍 Sha'Carri Richardson 前往全國錦標賽途中被捕
據美國媒體報道，7 月 27 日，就在俄勒岡州尤金市舉行的美國田徑協會（USATF）全國田徑錦標賽前幾天，奧運會接力賽金牌得主、25 歲的衛冕 100 米世界冠軍 Sha'Carri Richardson 在西雅圖塔科馬國際機場被捕並被短暫拘留。她被送往華盛頓州得梅因市的 SCORE 南懲教所；據了解，當局並未提出任何指控，Richardson 於第二天下午根據法院命令獲釋。 圖 / Getty 這位短跑運動員在全美錦標賽期間接受美國運動媒體 的採訪，但並未提及她被捕一事。 同時亦報道，Richardson 已退出全美錦標賽。而於 Richardson 疑被拘留的原因，直到目前仍未有更多資訊。 廣告 廣告 圖 / World Athletics 這並非 Richardson 第一次在旅途中惹上麻煩；2023 年初，她因與一名空中服務員發生爭執而被趕下美國航空的航班。2021 年，她獲得了東京奧運的參賽資格，但隨後在美國奧運選拔賽中藥檢中，被驗出大麻中的一種化學物質四氫大麻酚（THC）檢測呈陽性，被禁賽一個月。作為衛冕世界 100 米冠軍，Richardson 將自動獲得 2025 年世界錦標賽的外卡。 此文章由「香港運動筆記」最初發表於
Yahoo
a day ago
- Yahoo
DEA Accountability as Cannabis Research Crisis Deepens And Patients Suffer
With the confirmation of incoming DEA Administrator Terrance Cole, the opportunity for reform has arrived. The DEA must choose between outdated drug war politics and advancing public health. MMJ International Holdings Issues Clarification on Irvine Labs. WASHINGTON, DC / / August 1, 2025 / MMJ International Holdings, Inc. ("MMJ") today issued a public clarification regarding prior statements about Irvine Labs, Inc., while calling for an urgent reckoning with the U.S. Drug Enforcement Administration's (DEA) catastrophic mismanagement of America's cannabis research policy. In a previous press release, MMJ referenced widespread inactivity among DEA-registered marijuana manufacturers. While these statements were intended to highlight systemic failures within the DEA's quota and licensing system, MMJ acknowledges that this language may have unintentionally caused confusion regarding Irvine Labs, Inc. MMJ hereby clarifies that Irvine Labs, Inc. is a registered DEA entity and, to the best of MMJ's current knowledge, holds valid DEA registrations. MMJ did not intend to imply that Irvine Labs is inactive or insolvent, and any interpretation suggesting otherwise is hereby retracted. This clarification, however, does not alter the underlying crisis: the DEA's marijuana manufacturing quota system is fundamentally broken. Despite a supposed expansion of DEA licenses, no registrant-except MMJ-has produced sufficient pharmaceutical-grade cannabis to support a single FDA-compliant clinical trial. The Devastating Reality: Maridose (Maine): Only 1,100 sq. ft. of space, not growing. Bright Green Corp: Surrendered its registration without ever planting a crop. Royal Emerald Pharmaceuticals: Inactive and facing financial distress. Groff NA Hemplex & Scottsdale Research Institute: No active cultivation for clinical trials. BRC: Producing quantities far below clinical thresholds. University of Mississippi: Continues to grow substandard, research-incompatible marijuana. MMJ remains the only federally compliant entity actively pursuing the cultivation of strain-specific, pharmaceutical-grade cannabis for FDA-approved clinical trials targeting Huntington's Disease and Multiple Sclerosis. Yet, for over seven years, the DEA has obstructed MMJ's efforts through unconstitutional administrative proceedings, arbitrary quotas, and a bureaucratic "Catch-22" that demands documentation (BFSA) which is unattainable without the very registration the DEA refuses to grant. A Constitutional Crisis Exposed The Supreme Court's rulings in Axon v. FTC and Jarkesy v. SEC have now exposed the DEA's internal administrative law judge (ALJ) system as an unconstitutional charade. Despite this, DEA legal counsel Aarathi Haig continues to defend a system the Department of Justice has now abandoned. Former Chief ALJ John "McLooney" Mulrooney has since retired, leaving behind what critics call a "legal dumpster fire." MMJ's legal exceptions, filed July 3, 2025, detail the agency's structural bias, retroactive sabotage, and deliberate obstruction of medical research. "We followed every law, built the FDA-inspected facility, and secured our clinical approvals," said Duane Boise, CEO of MMJ International Holdings. "What the DEA calls regulation is nothing more than bureaucratic revenge." The Time for Reckoning is Now With the confirmation of incoming DEA Administrator Terrance Cole, the opportunity for reform has arrived. The DEA must choose between outdated drug war politics and advancing public health. This demands immediate action: Fire entrenched obstructionists like Thomas Prevoznik. Investigate Aarathi Haig for perpetuating unconstitutional legal processes. Transfer oversight of cannabis research to the FDA, where science-not sabotage-will guide policy. "The DEA has spent a decade fortifying a broken system that protects monopolies, obstructs innovation, and ignores public safety disasters like the Assured Testing Labs scandal in Massachusetts," said Boise. "America doesn't need another anti-marijuana crooner in a suit-it needs a leader who will stand up to this agency's sabotage and put patients first." MMJ International Holdings remains committed to factual accuracy and will continue to expose systemic failures that endanger patients, stifle science, and betray the public trust. MMJ is represented by attorney Megan Sheehan. CONTACT:Madison HiseyMHisey@ SOURCE: MMJ International Holdings View the original press release on ACCESS Newswire Sign in to access your portfolio
